Target intelligence / Profile preview

tRNA-guanine transglycosylase (Zymomonas mobilis) (TGT)

Target
TGT
Molecular classification
Enzyme, Transferase, Glycosyltransferase
01

Overview

tRNA-guanine transglycosylase (TGT) from Zymomonas mobilis is a homodimeric enzyme that plays a critical role in the post-transcriptional modification of tRNA. It catalyzes the site-specific replacement of guanine at the wobble position (G34) of tRNA(Asn, Asp, His, Tyr) with the precursor 7-aminomethyl-7-deazaguanine (preQ1), a key step in the biosynthesis of queuosine (UniProt: P28720). While Z. mobilis is a non-pathogenic bacterium, its TGT is highly homologous to the TGT found in Shigella species, making it a primary structural model for antibiotic drug discovery (PubMed: 10417330). In Shigella, TGT activity is essential for the translation of VirF, the master transcriptional activator of the virulence plasmid, which is required for the invasion of the human intestinal epithelium (PubMed: 12692131). Inhibition of TGT effectively disarms the pathogen by preventing the expression of its virulence machinery without necessarily killing the bacteria, potentially reducing the pressure for resistance (PubMed: 25654371). Numerous small-molecule inhibitors, particularly those based on the lin-benzoguanine scaffold, have been developed and characterized using the Z. mobilis enzyme as a surrogate (PubMed: 21417383).

Other names
Queuine tRNA-ribosyltransferaseGuanine insertion enzymetRNA-guanine 7-guanine transferaseZmTGT
02

Mechanism of action

Inhibition of the exchange of guanine with pre-queuosine (preQ1) at position 34 of tRNA, preventing the formation of queuosine-modified tRNA required for the translation of virulence factors.

03

Biological functions

tRNA modificationQueuosine biosynthesisPost-transcriptional regulation
04

Disease associations

InfectionShigellosis
05

Safety considerations

Selectivity over human TGTBacterial resistance developmentBioavailability of polar inhibitors
06

Interacting drugs

Lin-benzoguanine derivatives

1 more in the full profile.

07

Biomarkers

Queuosine-modified tRNA levelsVirF protein expression

Beyond the preview

Go deeper on tRNA-guanine transglycosylase (Zymomonas mobilis) (TGT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA-guanine transglycosylase (Zymomonas mobilis) (TGT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call